Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 40, 2010 - Issue 1
117
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Identification of cinobufagin metabolites in the bile of rats

, , , , , , & show all
Pages 48-54 | Received 01 Aug 2009, Accepted 13 Sep 2009, Published online: 06 Nov 2009
 

Abstract

  1. Cinobufagin (1) is a major bufadienolide in ChanSu (a traditional Chinese medicine) with a wide range of pharmacological activities. In this paper, the in vivo metabolites of 1 in rats were studied.

  2. Nine metabolites were isolated from the bile of rats, and their structures were identified as: desacetylcinobufagin (2), 3-ketodesacetylcinobufagin (3), 3-epi-desacetylcinobufagin (4); 5β-hydroxy-3-epi-desacetylcinobufagin (5), 1α-hydroxy-3-epi-desacetylcinobufagin (6), 12β-hydroxy-3-epi-desacetylcinobufagin (7), 1β-hydroxy-3-epi-desacetylcinobufagin (8), 1α,5α-dihydroxy-3-epi-desacetylcino-bufagin (9), and 2α, 5β-dihydroxy-3-epi-desacetylcinobufagin (10), respectively, on the basis of widely spectroscopic studies including two-dimensional-nuclear magnetic resonance (NMR). Among them, metabolites 6–10 are new compounds.

  3. The results show that hydroxylation is the main reaction involved in metabolism of 1, and the preferred hydroxylation sites were C-1 and C-5.

Acknowledgements

The authors thank the National Natural Science Foundation of China (Grant Number 30701088) and the Bureau of Science & Technology of Dalian City (Grant Number 2008J23JH042) for financial support.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.